Based on the findings of Rosati et al. [64], which demonstrate that tumor growth and metastasis is partially blocked with an anti-BAG3 murine antibody, secreted BAG3 may represent a potential target for the treatment of pancreatic cancer. This evidence concerns the gene BAG3 and familial pancreatic carcinoma.